Simplex Trading
AZN icon

Simplex Trading’s AstraZeneca AZN Stock Holding History

Simplex Trading’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Sell
58,700
-15,600
-21% -$3.01M 0.01% 644
2025
Q4 		$13.7M Buy
74,300
+28,100
+61% +$4.93M 0.01% 693
2025
Q3 		$7.09M Sell
46,200
-59,000
-56% -$8.93M ﹤0.01% 1188
2025
Q2 		$14.7M Sell
105,200
-193,800
-65% -$27.2M 0.01% 675
2025
Q1 		$44M Buy
299,000
+99,550
+50% +$14.4M 0.03% 301
2024
Q4 		$26.1M Buy
199,450
+61,050
+44% +$8.55M 0.01% 514
2024
Q3 		$21.6M Sell
138,400
-18,650
-12% -$3.01M 0.01% 615
2024
Q2 		$24.5M Buy
157,050
+13,400
+9% +$2.02M 0.02% 534
2024
Q1 		$19.5M Sell
143,650
-21,850
-13% -$2.89M 0.01% 710
2023
Q4 		$22.3M Sell
165,500
-126,550
-43% -$16.5M 0.01% 669
2023
Q3 		$39.6M Buy
292,050
+168,800
+137% +$23.1M 0.03% 348
2023
Q2 		$17.6M Sell
123,250
-41,300
-25% -$6.08M 0.01% 636
2023
Q1 		$22.8M Sell
164,550
-11,850
-7% -$1.59M 0.02% 535
2022
Q4 		$23.9M Buy
176,400
+38,950
+28% +$4.88M 0.03% 496
2022
Q3 		$15.1M Buy
137,450
+22,600
+20% +$2.87M 0.02% 616
2022
Q2 		$15.2M Sell
114,850
-121,900
-51% -$16M 0.02% 624
2022
Q1 		$31.4M Buy
236,750
+138,850
+142% +$16.7M 0.03% 402
2021
Q4 		$11.4M Sell
97,900
-170,000
-63% -$20M 0.01% 725
2021
Q3 		$32.3M Sell
267,900
-2,000
-0.7% -$233K 0.03% 329
2021
Q2 		$32.3M Buy
+269,900
New +$29.6M 0.03% 321
2021
Q1 		– Sell
-3,061
Closed -$30.6M – 8773
2020
Q4 		$30.6M Buy
3,061
+1,176
+62% +$125K 0.04% 261
2020
Q3 		$20.7M Sell
1,885
-257
-12% -$28.6K 0.03% 331
2020
Q2 		$22.7M Buy
2,142
+1,909
+819% +$197K 0.04% 283
2020
Q1 		$2.08M Sell
233
-76
-25% -$7.16K ﹤0.01% 1251
2019
Q4 		$3.08M Sell
309
-20
-6% -$1.88K 0.01% 1129
2019
Q3 		$2.93M Sell
329
-135
-29% -$11.7K 0.01% 1042
2019
Q2 		$3.83M Buy
464
+207
+81% +$16.2K 0.01% 842
2019
Q1 		$2.07M Sell
257
-2
-0.8% -$158 0.01% 1347
2018
Q4 		$1.96M Sell
259
-396
-60% -$30.9K 0.01% 1105
2018
Q3 		$5.18M Buy
655
+177
+37% +$13.4K 0.02% 601
2018
Q2 		$3.35M Buy
478
+369
+339% +$26.5K 0.01% 782
2018
Q1 		$36K Sell
109
-289
-73% -$20K ﹤0.01% 2745
2017
Q4 		$161K Sell
398
-279
-41% -$18.8K 0.01% 1437
2017
Q3 		$308K Sell
677
-441
-39% -$27.9K 0.01% 941
2017
Q2 		$495K Buy
1,118
+34
+3% +$2.22K 0.02% 662
2017
Q1 		$333K Buy
1,084
+616
+132% +$35.9K 0.01% 907
2016
Q4 		$66K Buy
468
+374
+398% +$21.2K ﹤0.01% 1884
2016
Q3 		$42K Sell
94
-53
-36% -$3.46K ﹤0.01% 2239
2016
Q2 		$23K Buy
147
+51
+53% +$2.96K ﹤0.01% 2763
2016
Q1 		$2K Sell
96
-265
-73% -$15.9K ﹤0.01% 4664
2015
Q4 		$9K Sell
361
-222
-38% -$14.6K ﹤0.01% 3369
2015
Q3 		$9K Sell
583
-40
-6% -$2.63K ﹤0.01% 3519
2015
Q2 		$19K Buy
623
+56
+10% +$3.83K ﹤0.01% 2497
2015
Q1 		$30K Buy
+567
New +$39.4K ﹤0.01% 1964

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Simplex Trading's AZN Position: Q1 2026 in Review

Simplex Trading opened a new position in AstraZeneca (AZN) in Q1 2026: 7,753 shares worth $1.53M. The stake represents ﹤0.01% of the portfolio and ranks #2068 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AZN as recently as Q3 2025.

Simplex Trading first reported a position in AZN in Q4 2014 and has held it in 29 quarters since. The position peaked at $13.5M in Q4 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Simplex Trading held 7,753 shares of AstraZeneca worth $1.53M as of Q1 2026.
  • AstraZeneca was a new Simplex Trading position in Q1 2026.
  • AstraZeneca made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2068 holding.
  • Simplex Trading first reported a position in AstraZeneca in Q4 2014 and has held it in 29 quarters since.
  • Simplex Trading's AstraZeneca position peaked at $13.5M in Q4 2021.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.